These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 33852781)
21. Microalbuminuria and proximal tubule remodeling in the cardiometabolic syndrome. Hayden MR; Chowdhury NA; Witte L; Sowers JR J Cardiometab Syndr; 2006; 1(2):107-14. PubMed ID: 17679822 [TBL] [Abstract][Full Text] [Related]
22. MiR-21 is up-regulated in urinary exosomes of chronic kidney disease patients and after glomerular injury. Lange T; Artelt N; Kindt F; Stracke S; Rettig R; Lendeckel U; Chadjichristos CE; Kavvadas P; Chatziantoniou C; Endlich K; Endlich N J Cell Mol Med; 2019 Jul; 23(7):4839-4843. PubMed ID: 31066165 [No Abstract] [Full Text] [Related]
23. Microalbuminuria and normal protein filtration in the kidney. Shand B N Z Med J; 1987 Feb; 100(818):108-10. PubMed ID: 3470668 [No Abstract] [Full Text] [Related]
24. Molecular make-up of the glomerular filtration barrier. Patrakka J; Tryggvason K Biochem Biophys Res Commun; 2010 May; 396(1):164-9. PubMed ID: 20494132 [TBL] [Abstract][Full Text] [Related]
25. FYVE domain-containing protein ZFYVE28 regulates EGFR-signaling in podocytes but is not critical for the function of filtration barrier in mice. Zambrano S; Rodriguez PQ; Guo J; Möller-Hackbarth K; Schwarz A; Patrakka J Sci Rep; 2018 Mar; 8(1):4712. PubMed ID: 29549365 [TBL] [Abstract][Full Text] [Related]
26. Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic? Marshall CB Am J Physiol Renal Physiol; 2016 Nov; 311(5):F831-F843. PubMed ID: 27582102 [TBL] [Abstract][Full Text] [Related]
28. Review of recent literature in hypertension: updated clinical practice guidelines for chronic kidney disease now include albuminuria in the classification system. Bloch MJ; Basile JN J Clin Hypertens (Greenwich); 2013 Dec; 15(12):865-7. PubMed ID: 24119153 [No Abstract] [Full Text] [Related]
29. Adiponectin promotes functional recovery after podocyte ablation. Rutkowski JM; Wang ZV; Park AS; Zhang J; Zhang D; Hu MC; Moe OW; Susztak K; Scherer PE J Am Soc Nephrol; 2013 Feb; 24(2):268-82. PubMed ID: 23334396 [TBL] [Abstract][Full Text] [Related]
30. Estimated GFR or albuminuria: which one is really associated with resistant hypertension? Romero CA; Peixoto AJ; Orias M Semin Nephrol; 2014; 34(5):492-7. PubMed ID: 25416657 [TBL] [Abstract][Full Text] [Related]
31. The case for using albuminuria in staging chronic kidney disease. Gansevoort RT; de Jong PE J Am Soc Nephrol; 2009 Mar; 20(3):465-8. PubMed ID: 19255126 [No Abstract] [Full Text] [Related]
32. Yet another advance in understanding albuminuria? Molitoris BA J Am Soc Nephrol; 2010 Dec; 21(12):2013-5. PubMed ID: 21051742 [No Abstract] [Full Text] [Related]
33. [Novel insights into the glomerular structure]. Moeller MJ Dtsch Med Wochenschr; 2010 Jun; 135(24):1232-6. PubMed ID: 20533157 [TBL] [Abstract][Full Text] [Related]
34. Glomerular endothelial cell injury and cross talk in diabetic kidney disease. Fu J; Lee K; Chuang PY; Liu Z; He JC Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387 [TBL] [Abstract][Full Text] [Related]
35. Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier. Jarad G; Cunningham J; Shaw AS; Miner JH J Clin Invest; 2006 Aug; 116(8):2272-9. PubMed ID: 16886065 [TBL] [Abstract][Full Text] [Related]
36. Glomerular Endothelium and its Impact on Glomerular Filtration Barrier in Diabetes: Are the Gaps Still Illusive? Ndisang JF Curr Med Chem; 2018; 25(13):1525-1529. PubMed ID: 28685678 [TBL] [Abstract][Full Text] [Related]
37. Renal vascular structural properties and their alterations by removal of uraemic toxins in a rat model of chronic kidney disease. Yamazaki H; Tomoda F; Koike T; Kinuno H; Sugimori H; Inoue H; Bannai K; Sugano M; Nishijima F Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):238-45. PubMed ID: 24471839 [TBL] [Abstract][Full Text] [Related]
39. Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway. Ichikawa H; Shimada M; Narita M; Narita I; Kimura Y; Tanaka M; Osanai T; Okumura K; Tomita H J Am Heart Assoc; 2019 Apr; 8(8):e012195. PubMed ID: 30957622 [TBL] [Abstract][Full Text] [Related]
40. Knockdown of the hypertension-associated gene NOSTRIN alters glomerular barrier function in zebrafish (Danio rerio). Kirsch T; Kaufeld J; Korstanje R; Hentschel DM; Staggs L; Bollig F; Beese M; Schroder P; Boehme L; Haller H; Schiffer M Hypertension; 2013 Oct; 62(4):726-30. PubMed ID: 23959558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]